In a cloud lab world, you can generate meaningful proof of concept before you’ve raised a dollar or hired anyone. That reorders everything downstream. Instead of pitching an idea, you can bring evidence. Instead of convincing someone to bet on your judgment, you can show them your data and ask them to help you scale it. That’s a fundamentally different conversation, and a fundamentally different kind of company gets to start from it.
Why PXR Matters The pregnane X receptor, or PXR, is a nuclear hormone receptor that sits in the cell like a smoke alarm for xenobiotics. When a foreign molecule (including many drug candidates) binds to PXR’s ligand-binding domain, PXR moves to the nucleus and activates the transcription of drug-metabolizing enzymes — most critically CYP3A4, the…
Education Options for the Bench Scientist 2025 Comprehensive Guide The biotech industry faces a critical skills gap as artificial intelligence transforms drug discovery, clinical trials, and laboratory research. This comprehensive analysis of 65+ educational programs reveals unprecedented opportunities for scientists and researchers to gain AI/ML expertise—from free online courses to prestigious university degrees—with options spanning…
Market Landscape, Applications, and Opportunities for Small Research Teams Overview The biotech and pharma sectors stand at a critical juncture, pressured by the rapid advancement and adoption of Artificial Intelligence (AI). Moving beyond traditional predictive modeling and data analysis, a new paradigm of AI agents, also known as agentic AI, is emerging as of early…
Executive Summary The integration of artificial intelligence (AI) into RNA therapeutics and lipid nanoparticle (LNP) development represents a promising area in modern biopharmaceutical research. This report examines the significant advancements in applying machine learning, deep learning, and other AI technologies to accelerate and enhance the design, optimization, and delivery of RNA-based medicines. The remarkable success…
My recent vision has been one of a fully integrated, cooperative biotech ecosystem engaging all small biotech therapeutics companies in Massachusetts, using AI to achieve collective progress together. This vision is for a world that I’ve coined “eutopia”. I actually do think the outlook for small biotechs in Massachusetts is rosy, but the uncertainty and…